QuotePatients with severe GERD used proton pump inhibitors after antireflux surgery at much higher rates than previously reported, and more than half became long-term users 10 to 15 years after surgery, according to recent study data.
QuoteA study published in The American Journal of Gastroenterology showed 71% of patients prescribed proton pump inhibitors by a gastroenterologist were optimal users, compared with 47% of those who got a prescription from a primary care physician and 39% who purchased an over-the-counter form of the medication.
QuoteThree-dimensional models reconstructed from MRI images revealed a wider esophagogastric insertion angle plus altered gastric morphology that could compromise reflux protection by the "flap valve" mechanism in patients with gastroesophageal reflux disease (GERD).
QuoteKaiser researchers have linked long-term use of a popular type of antacid medication to vitamin B-12 deficiency, a condition that when left untreated can increase the risk of dementia, nerve damage, anemia and other potentially serious medical problems.
QuotePatients with Barrett's esophagus who used proton pump inhibitors (PPIs) had a lower risk of esophageal adenocarcinoma, in a systematic review and meta-analysis of seven observational studies.
QuoteSurgeons at the Perelman School of Medicine at the University of Pennsylvania in Philadelphia, however, are waiting for more evidence before they adopt MSA as a procedure
QuotePatients who received therapy with proton pump inhibitors were more likely to develop Clostridium difficile infection while hospitalized than those who did not in a recent study.
Quote
In human tissue and mouse models, researchers from Houston Methodist Hospital and two other institutions found proton pump inhibitors (PPIs) caused the constriction of blood vessels. If taken regularly, PPIs could lead to a variety of cardiovascular problems